Previous close | 119.38 |
Open | 118.00 |
Bid | 112.61 x 1000 |
Ask | 119.88 x 900 |
Day's range | 116.09 - 118.65 |
52-week range | 105.31 - 165.03 |
Volume | |
Avg. volume | 1,665,882 |
Market cap | 25.019B |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | 112.08 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.96 (0.82%) |
Ex-dividend date | 28 Mar 2022 |
1y target est | N/A |
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.
Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?